# Monopar Therapeutics > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1 | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:8816cde2-62f8-4a0c-8392-4fc559b683f2 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/monopar-therapeutics | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 22 | | Claims under review | 1 | | Evidence records | 6 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-03T15:55:46.6026+00:00 | | Last reviewed | 2026-10-03T15:55:46.6026+00:00 | ## Identity - Legal name: Monopar Therapeutics - Display name: Monopar Therapeutics ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:13: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:raymond-w-anderson-mba-ms","name":"Raymond W. Anderson, MBA MS"},"source_id":"board_seats"}` - Claim alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:14: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:arthur-j-klausner-mba","name":"Arthur J. Klausner, MBA"},"source_id":"board_seats"}` - Claim alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:15: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:lavina-talukdar-cfa","name":"Lavina Talukdar, CFA"},"source_id":"board_seats"}` - Claim alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"chair","person":{"alpha_id":"alpha:person:raymond-w-anderson-mba-ms","name":"Raymond W. Anderson, MBA MS"},"source_id":"board_seats"}` - Claim alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:arthur-j-klausner-mba","name":"Arthur J. Klausner, MBA"},"source_id":"board_seats"}` - Claim alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:19: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:lavina-talukdar-cfa","name":"Lavina Talukdar, CFA"},"source_id":"board_seats"}` - Claim alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"chair","person":{"alpha_id":"alpha:person:arthur-j-klausner-mba","name":"Arthur J. Klausner, MBA"},"source_id":"board_seats"}` - Claim alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:22: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:lavina-talukdar-cfa","name":"Lavina Talukdar, CFA"},"source_id":"board_seats"}` - Claim alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:raymond-w-anderson-mba-ms","name":"Raymond W. Anderson, MBA MS"},"source_id":"board_seats"}` ## Leadership - Arthur J. Klausner, MBA: Director, Audit; Compensation; Nominating and Governance · Chair. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:5. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:2. - Chandler D. Robinson, MD MBA MSc: Director. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:6. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:2. - Christopher M. Starr, PhD: Director. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:7. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:2. - Kim R. Tsuchimoto: Director. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:8. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:2. - Lavina Talukdar, CFA: Director, Audit; Compensation; Nominating and Governance. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:9. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:2. - Raymond W. Anderson, MBA MS: Director, Audit · Chair; Compensation · Chair; Nominating and Governance. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:10. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:2. - Chandler D. Robinson: CEO, Co-Founder and Director. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:leadership_role:11. Valid from: 2026-04-30. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:3. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Raymond W. Anderson, MBA MS; Members Raymond W. Anderson, MBA MS (Chair); Arthur J. Klausner, MBA; Lavina Talukdar, CFA. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_record:12. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:4. - Compensation: Chair Raymond W. Anderson, MBA MS; Members Raymond W. Anderson, MBA MS (Chair); Arthur J. Klausner, MBA; Lavina Talukdar, CFA. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:5. - Nominating and Governance: Chair Arthur J. Klausner, MBA; Members Arthur J. Klausner, MBA (Chair); Lavina Talukdar, CFA; Raymond W. Anderson, MBA MS. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_record:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:6. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Monopar Therapeutics. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:1. ## Entity Status - Public listing published. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:1. ## Published Fact - US. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:1. ## Committee Appointment - Raymond W. Anderson, MBA MS: chair, Audit. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:4. - Arthur J. Klausner, MBA: member, Audit. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:4. - Lavina Talukdar, CFA: member, Audit. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:4. - Raymond W. Anderson, MBA MS: chair, Compensation. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:5. - Arthur J. Klausner, MBA: member, Compensation. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:5. - Lavina Talukdar, CFA: member, Compensation. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:5. - Arthur J. Klausner, MBA: chair, Nominating and Governance. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:6. - Lavina Talukdar, CFA: member, Nominating and Governance. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:6. - Raymond W. Anderson, MBA MS: member, Nominating and Governance. Claim: alpha:claim:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:6. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/monopar-therapeutics). - alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:2: [Monopar Therapeutics DEF 14A 2025-04-30](https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm). - alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:3: [MNPR DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1645469/000143774926014183/mnpr20260330_def14a.htm). - alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:4: [Audit](https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm). - alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:5: [Compensation](https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm). - alpha:evidence:company:8816cde2-62f8-4a0c-8392-4fc559b683f2:6: [Nominating and Governance](https://www.sec.gov/Archives/edgar/data/1645469/000143774925013824/mnpr20250418_def14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/monopar-therapeutics) - [Public Markdown](https://registry.alpha.ac/companies/monopar-therapeutics.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/monopar-therapeutics?format=jsonld) - MCP resource: `alpha://companies/monopar-therapeutics` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible.